Document is current
Any future updates will be listed below
-
Authors
Ulfstedt, Johan Mattsson
Risebro, Ragnhild
Freyhult, Eva
Christersson, Christina
Mörth, Charlott
Kamali-Moghaddam, Masood
Robelius, Anna
Enblad, Gunilla
Molin, Daniel
-
Funding
Funding for this research was provided by:
Uppsala University
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 13 December 2025
First Online: 26 December 2025
Declarations
:
: EDTA plasma samples were released from the U-CAN biobank for the plasma proteome analysis under ethical approval (dnr. 2013/059 and dnr. 2014/233). Data collection in the EpiHealth study and usage of the material in this project was approved by the Ethics Committee of Uppsala (dnr. 2010/402: 2010-12-01, 2011-11-17, dnr. 2015/179).
: Not applicable.
: Christina Christersson: Speaker fees from Novartis.Gunilla Enblad: Scientific advisor for Sprint Bioscience, XNK Therapeutics, and Elicera. Avisory board of Gilead. Speaker fees from Pierre Fabre and Roche.Daniel Molin: Previously speaker fees from Roche, Merck, Bristol-Myers Squibb, and Takeda.
